Neurontin
In 1994, the Food and Drug Administration (FDA) approved Neurontin, also known as gabapentin, for the treatment of partial seizures in adults and children. Neurontin is manufactured by Pfizer Inc., the world's largest research-based pharmaceuticals firm. Neurontin is also FDA-approved for the management of postherpetic neuralgia (PHN), the nerve pain experienced by shingles sufferers. Shortly after its introduction, U.S. Neurontin sales grew rapidly and generated more than $1.3 billion in revenues over its first full year.
Today, Pfizer is under investigation in 47 States for illegally marketing Neurontin for non-FDA approved uses. In May 2004, Pfizer plead guilty to two felony counts of violating the Food, Drug and Cosmetic Act in a federal lawsuit and agreed to pay more than $430 million as a penalty for selling Neurontin for purposes that have not yet been FDA approved. Pfizer had implemented various marketing and sales approaches to illegally promote Neurontin for off-label uses, including making misleading statements about the drug. The government is now seeking damages from the illegal marketing strategies.
Patients who have used Neurontin for non-FDA approved use have been found to be at an elevated risk for serious side effects, including suicidal tendencies. The numbers of patients who have used Neurontin for treatment of a non-FDA approved use are estimated at an astounding 40% of all prescriptions. Neurontin remains on the market for its FDA approved purposes. If you or a loved one has taken Neurontin, also known as gabapentin), we will evaluate your case absolutely free. If Neurontin has injured you or a loved one, our legal team will aggressively fight for your rights. You may be entitled to compensation.
<< back
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
